Situación actual de las enfermedades huérfanas en Bogotá: notificación al Sivigila entre el año 2019 y 2022
2023

Current Situation of Rare Diseases in Bogotá (2019-2022)

Sample size: 10399 publication 10 minutes Evidence: moderate

Author Information

Author(s): Serrano-Giraldo Julián, Becerra-Muñoz Martha P., Tijaro-Santos Jennifer A., Zarante Ignacio

Primary Institution: Instituto de Salud Publica, Facultad de Medicina - Universidad Nacional de Colombia

Hypothesis

To analyze the reports of orphan diseases in Bogotá, in order to describe the epidemiological profile.

Conclusion

There is an under-registration of patients with orphan diseases in Bogotá, and a significant delay in diagnosis is evident.

Supporting Evidence

  • 10,399 patients with orphan diseases were reported in Bogotá from January 2019 to March 2022.
  • The most reported orphan disease was multiple sclerosis, accounting for 13.1% of cases.
  • Patients took an average of 61.3 months to receive a diagnosis after symptoms began.
  • 87.10% of cases belonged to the contributory health regime.
  • Suba was the locality with the highest number of reports, accounting for 15.85% of cases.

Takeaway

This study looked at how many people in Bogotá have rare diseases and found that many are not reported, and it takes a long time for patients to get diagnosed.

Methodology

A descriptive and cross-sectional study analyzing cases reported to the Sivigila from January 2019 to March 2022.

Potential Biases

Potential bias due to incomplete data in reporting forms.

Limitations

The study relied solely on reports to Sivigila, which may not reflect the true prevalence of orphan diseases.

Participant Demographics

56.25% female and 43.75% male, with most cases in the age group of 25 to 60 years.

Digital Object Identifier (DOI)

10.15446/rsap.V25n4.107594

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication